Catalogo dei prodotti della ricerca

CICONE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.766
EU - Europa 497
AS - Asia 264
SA - Sud America 9
AF - Africa 7
Totale 2.543
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.752
IT - Italia 140
SG - Singapore 110
SE - Svezia 107
FI - Finlandia 81
IN - India 75
CN - Cina 70
UA - Ucraina 40
DE - Germania 34
IE - Irlanda 28
CA - Canada 13
CH - Svizzera 13
AT - Austria 11
GB - Regno Unito 10
AR - Argentina 9
ID - Indonesia 8
BG - Bulgaria 7
RO - Romania 7
TG - Togo 6
GR - Grecia 5
RU - Federazione Russa 5
BE - Belgio 3
FR - Francia 3
NL - Olanda 3
IL - Israele 1
MX - Messico 1
SC - Seychelles 1
Totale 2.543
Salva come PNG Salva come JPEG
Città #
Fairfield 340
Woodbridge 158
Seattle 137
Ashburn 127
Cambridge 114
Houston 113
Wilmington 108
Chandler 95
Singapore 86
Ann Arbor 64
Rome 53
Beijing 52
Helsinki 47
Princeton 46
Plano 41
San Paolo di Civitate 30
Dublin 28
Lawrence 26
Boston 24
Bremen 21
Santa Clara 21
San Diego 18
Dearborn 17
Millbury 17
Jacksonville 16
Andover 13
New York 12
Norwalk 12
Lausanne 11
Vienna 10
Falls Church 9
Federal 9
Toronto 9
Jakarta 8
Des Moines 7
Fremont 7
Sofia 7
Lomé 6
Bolzano Vicentino 5
Falkenstein 4
Mannheim 4
Milan 4
Ottawa 4
Phoenix 4
Boardman 3
Brussels 3
Kunming 3
Los Angeles 3
Salerno 3
San Mateo 3
Verona 3
Augusta 2
Bari 2
Bern 2
Bühl 2
Fuzhou 2
Hebei 2
L'aquila 2
Le Casine-Perignano-Spinelli 2
Mazzano Romano 2
Nanjing 2
Redmond 2
Romola 2
Springfield 2
Athens 1
Azor 1
Buffalo 1
Cernusco sul Naviglio 1
Chengdu 1
Dallas 1
Edinburgh 1
Florence 1
Fort Worth 1
Genzano Di Lucania 1
Grafing 1
Hangzhou 1
Jinan 1
Kaluga 1
Kilburn 1
Nanchang 1
Naples 1
Nuremberg 1
Padova 1
Palmetto 1
Philadelphia 1
Portland 1
Pune 1
San Francisco 1
Shanghai 1
Simi Valley 1
Southend 1
Southwark 1
Vasanello 1
Wenzhou 1
Xi'an 1
Yellow Springs 1
Totale 2.023
Salva come PNG Salva come JPEG
Nome #
Thyro-entero-gastric autoimmunity. Pathophysiology and implications for patient management 109
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery. 100
Tc-99m DTPA Cisternography Shows Disappearance of Cerebrospinal Fluid Leakage After Standing a Short Time 95
Repeated stereotactic radiosurgery for patients with progressive brain metastases 94
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer. a prospective study 90
Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma 87
Hyperhomocysteinemia in acute iatrogenic hypothyroidism. The relevance of thyroid autoimmunity 86
The importance of standardizing acquisition settings and interpretation criteria of radionuclide cisternography. 82
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with (90)Y-ibritumomab tiuxetan (Zevalin) 81
Cardiac radionuclide imaging in rodents. A review of methods, results, and factors at play 78
Dosimetry-based treatment planning for molecular radiotherapy. A summary of the 2017 report from the Internal dosimetry task force 74
Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after 90 Y-ibritumomab-tiuxetan 74
Studying the metabolic activity of red bone marrow by means of FDG-PET: The need for a standardization 72
Amino acid PET and MR perfusion imaging in brain tumours 72
Multiparametric evaluation of low grade gliomas at follow-up. comparison between diffusion and perfusion MR with (18)F-FDOPA PET 70
First in-human radiation dosimetry of (68)Ga-NODAGA-RGDyK 68
Imaging the future: a report from the Young Daily EANM Forum 2013 66
Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases 63
Comment on Hatzoglou et al: Dynamic contrast-enhanced MRI perfusion versus 18FDG PET/CT in differentiating brain tumor progression from radiation injury 61
null 59
Effect of a pre-University orientation course on applicants’ ranking in the medical admission test. 58
null 57
F-DOPA PET identifies high tumor grade and anaplastic transformation in non-enhancing gliomas 56
Variations in the practice of molecular radiotherapy and implementation of dosimetry. Results from a european survey 54
null 52
null 50
Malignant Lymphoma in Children 47
Quantification of dose nonuniformities by voxel-based dosimetry in patients receiving 90Y-ibritumomab-tiuxetan. 47
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck 47
null 46
Radioimmunotherapy of Heavily Pre-treated, Non-Hodgkin's Lymphoma Patients: Efficacy and Safety in a Routine Setting 44
null 42
Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan. 40
Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist? 40
Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia. 39
“Boom-Boom” radioimmunotherapy of lymphomas. Are two magic bullets better than one? 38
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes. A Cardiac Dynamic 18F-FDG-PET Study 30
Challenging adsorbed doses to lesions receiving Y-90-ibritumomab-tiuxetan: two vs three-dimensional estimations and their correlations with clinical outcome 29
Anatomical substrates of cognitive and clinical dimensions in first episode schizophrenia 27
ROLE OF 18F-DOPA PET/CT IN NON-ENHANCING GLIOMAS 25
null 23
null 22
null 20
Long term follow up of radionecrotic brain metastases assessed by serial F-DOPA PET/CT scans 20
18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma 18
null 18
18F-DOpA uptake parameters in glioma: Effects of patients’ characteristics and prior treatment history 17
Value of F-DOPA PET in the long term follow up of radionecrotic brain metastases after radiosurgery: comparison with MRI 16
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI 16
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes. The randomized, open-label, crossover, active-comparator FIORE trial 15
Single-fraction versus multifraction (3 × 9 gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis 15
(18)F-DOPA Positron emission tomography inmedulloblastoma. 2 Case reports 14
Metabolic Evolution of Brain Metastasis After Stereotactic Radiosurgery: Mismatch Between F-DOPA and FDG PET 13
La serotonina e la mente suicida: i contributi degli studi biologici e dell'imaging medico nucleare. 7
null 4
Why not consider PET/CT in the workup of pulmonary tumour thrombotic microangiopathy? 4
null 3
null 3
null 3
null 3
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group 3
null 3
null 3
Correction to: Repeated amino acid PET imaging for longitudinal monitoring of brain tumors (Clinical and Translational Imaging, (2022), 10, 5, (457-465), 10.1007/s40336-022-00504-w) 1
Correction to: Repeated amino acid PET imaging for longitudinal monitoring of brain tumors (Clinical and Translational Imaging, (2022), 10, 5, (457-465), 10.1007/s40336-022-00504-w) 1
Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET 1
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group 1
Totale 2.716
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.842
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020538 0 0 0 0 68 79 105 86 77 44 60 19
2020/2021222 24 30 7 28 17 16 2 17 25 38 16 2
2021/2022425 5 33 39 18 55 13 11 51 34 28 50 88
2022/2023462 92 110 43 47 35 43 4 31 38 1 16 2
2023/2024221 14 23 14 21 11 22 1 51 7 16 20 21
2024/2025149 6 48 43 17 35 0 0 0 0 0 0 0
Totale 2.716